Pay in 4 interest-free payments of $28.26 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
InChi: InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26
The subcutaneous tumor growth of both T24 and HeLa cell xenografts treated with PAI-039 is markedly reduced compared with untreated controls
(R)-(-)-Ibuprofen inhibits NF-κB luciferase activity with an IC50 of 121
a synthetic phenoxy-isobutyric acid derivate with antihyperlipidemic activity
BMS-378806 Catalog No.:M10727-10 InChi: InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26BMS 378806 is a small molecule that inhibits the first step of HIV 1 infection by blocking the binding of host cell CD4 with viral gp120 protein. It binds the exterior envelope glycoprotein gp120 (Kd= 21. 1 nM; Ki = 24. 9 nM), blocking the conformational change that occurs with CD4 binding and preventing fusion of the viral and target cell membranes. Product information CAS Number: 357263 13 9 Molecular Weight: 406. 43 Formula: C22H22N4O4 Chemical